Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
Weill Medical College of Cornell University · NCT05562778
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 150
- US sites recruiting
- 4
- Study start
- January 15, 2023
- Record last updated
- June 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive. This comparison will enable the investigators to determine if the chatbot system can improve rates of recommendation for genetic testing among patients at elevated risk of harboring a familial cancer syndrome in an all-Medicaid gynecology clinic. Furthermore, the investigators aim to evaluate facilitators of inequity in regard to patient access to and utilization of genetic testing services.
Being studied: Chatbot
Conditions: Gynecologic Cancer; Hereditary Cancer Syndrome
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 8 years of age or older.
- Scheduled for a New Patient appointment in the gynecology clinic. Speaks and reads in English.
- Access to a telephone with texting capacity.
- Has not had prior genetic testing for hereditary cancer syndromes.
Exclusion Criteria
- Under 18 years of age
- Has had previous genetic testing for hereditary cancer syndromes
- Does not read/speak in English
- Does not have access to a phone with texting capabilities
Recruiting US locations
NYP Brooklyn Methodist Hospital
Brooklyn, NY 11215
Site contact: Denise Howard, MD, MPH · 718-362-3260
NYP Lower Manhattan Hospital
New York, NY 10038
Site contact: Julia Cron, MD, FACOG · 646-962-2620
Weill Cornell Medicine
New York, NY 10065
Site contact: Melissa K Frey, MD, MS · 212-746-3049 · mkf2002@med.cornell.edu
NYP Medical Group Queens
Queens, NY 11375
Site contact: David Fishman, MD · 718-670-1731
Study contacts (from the official record)
- Melissa K Frey, MD, MS · 212-746-3049 · mkf2002@med.cornell.edu
- Elise Barrow, MPH · ecb4001@med.cornell.edu
Similar studies in New York
All healthy volunteers studies in New York →- RecruitingHealthy volunteers
Using Middle School Science Teachers to Address Cancer Health Disparities
Weill Medical College of Cornell University
- Location
- New York, NY + 1 other US site
- Eligibility basics
- Ages 10+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- New York, NY + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Staten Island, NY + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- East Syracuse, NY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1